86 results found.
        
Company Revenue 2015: Globus Medical
2015: $544.8MM, +16.0% CC (U.S. $498.1MM, +16.6%; ex-U.S. $46.5MM, +10.2% CC) 4Q15: $142.6MM, +11.5% CC ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows. Spine $520.0MM, +14.2% Orthobiologics $24.5MM, +29.1% ...
SeaSpine Reports Preliminary 4Q15 and 2015 Revenue
SeaSpine announced preliminary 2015 sales of ~US $133.5MM and 4Q15 sales of ~$35MM, flat v...
Globus Medical Reports Preliminary 4Q15 and 2015 Revenue
Globus Medical announced preliminary unaudited 2015 sales of ~US $544.7MM, +16.0% from 2014, and 4Q15 sales
Globus Medical 3Q15 Revenue Grows Nearly 18 Percent CC
Globus Medical reported 3Q15 sales of US $136.9MM, +16.3% from 3Q14 as reported, +17.6% in constant cur...
BARE BONES® - July 30, 2015
Globus Medical reported 2Q15 sales of US $133.6MM, +19.1% from 2Q14. (Innovative Fusion $71.5MM, +8.6%; Disruptive Technology $61.9MM, +29.9%) Growth reflects constanct currency. (
BARE BONES® - May 5, 2015
Globus Medical reported 1Q15 sales of US $131.6MM, +16.4% from 1Q14. (Innovative Fusion $70.3MM, +5.3%; Disruptive Technology $61.2MM, +29%) Growth reflects constanct currency. (
BARE BONES® - February 25, 2015
Globus Medical posted 4Q14 sales of US $128.8MMM, +11.8% from 4Q13, and 2014 sales of $474.4MM, +9.2% vs. 2013. (
2014 Revenue: Globus Medical
4Q14 revenue: $128.8MMM, +12% (U.S. +13%, ex-U.S. +10%) 2014 revenue: $474.4MM, +9% (U.S. $427.0MM, +8%; ex-U.S. $47.2MM, +25%) Innovative Fusion $270.8MM, +7% Disruptive Technology $203.5MM, +13%   ...
BARE BONES® - January 6, 2015
Globus Medical announced preliminary unaudited 2014 sales of ~US $474MM, +9.1% from 2013, and 4Q14 sales of ~$128.5MM, +11.5% from 4Q13. (
BARE BONES® - October 30, 2014
Globus Medical posted 3Q14 sales of US $117.8MM, +9.9% from 3Q13. (U.S. +8.7%, ex-U.S. +23.2%) (
3Q14 Revenue: Globus Medical
$117.8MM, +10% (U.S. +9%, ex-U.S. +23%) Innovative Fusion $67.7MM, +8% Disruptive Technologies $50.1MM, +12%   Expanded rollout of CREO next-gen pedicle screw platform, launched SILC low-profile sublaminar fixation syst...
BARE BONES® - August 6, 2014
Globus Medical reported 2Q14 sales of US $113.6MM, +6.1% from 2Q13. (U.S. +3.6%, ex-U.S. +34.1%) (
2Q14 Revenue: Globus Medical
$113.6MM, +6% (U.S. $101.6MM, +4%; ex-U.S. $11.9MM, +34%) Innovative Fusion $65.8MM, +5% Disruptive Technology $47.7MM, +8%   Low U.S. sales growth attributed to nonrenewal of contract with significant U.S. distributor,...
BARE BONES® - April 29, 2014
Globus Medical reported 1Q14 sales of US $114.2MM, +8.8% from 1Q13. (U.S. +5.6%, ex-U.S. +43%) (
1Q14 Revenue: Globus Medical
$114.2MM, +9% (U.S. $101.7MM, +6%; ex-U.S. $12.5MM, +43%) Innovative Fusion $66.8MM, +9% Disruptive Technology $47.4MM, +9%   Growth impacted by severe U.S .weather Price pressure remains in low- to mid-s...
4Q13/2013 Revenue: Bacterin
4Q13 tissue revenue: $8.3MM, +2% 2013 tissue revenue: $33.1MM, flat Business model going forward: direct sales to orthopaedics and neurosurgery via hybrid model; exploring private label relationships Increased productivity: 25 sal...
BARE BONES® - February 27, 2014
Globus Medical posted 4Q13 sales of US $115.2MM, +14.6% from 4Q12, and 2013 sales of $434.5MM, +12.6% vs. 2012. (
4Q13/2013 Revenue: Globus Medical
4Q13 revenue: $115.2MM, +15% (U.S. $104.1MM, +13%; ex-U.S. $11.1MM, +29%) Innovative Fusion $67.1MM, +15% Disruptive Technology $48.1MM, +14%   CREO pedicle screw + increased reps supported growth ...
4Q13/2013 Revenue: Mazor Robotics
4Q13 revenue: $5.7MM, +111% (U.S. $4.2MM, +200%; ex-U.S. $1.5MM, +15%) 2013 revenue: $20.0MM, +64% Sold 23 systems globally; installed base now 63 (34 in U.S.) 65% of spine cases using Renaissance were multi-level/complex, with 1/...
BARE BONES® - January 14, 2014
Globus Medical announced preliminary 4Q13 sales of US $115.2MM, +14.6% vs. 4Q12, and preliminary 2013 sales of $434.5MM, +12.6% from 2012. (
BARE BONES® - October 31, 2013
Globus Medical posted 3Q13 sales of US $107.2MM, +13% from 3Q12. (U.S. +13%, ex-U.S. +19%) (
3Q13 Revenue: Globus Medical
$107.2MM, +13% (U.S. $98.1MM, +13%; ex-U.S. $9.1MM, +19%) Disruptive Technology $45MM, +21% Innovative Fusion $63MM, +8%   Pricing pressure remains in low to middle single digits Payor pushback seems to h...
Web Exclusive: Highlights from THE SPINE MARKET report
In 2012, revenues generated by global sales of spinal implants and instrumentation reached an estimated $7.35 billion. Though historic double-digit growth in the segment flattened in 2010, looking ahead, conservative increases should occur based upon a shift in focus to more cervical discs, la...
BARE BONES® - August 1, 2013
Globus Medical reported 2Q13 sales of US $107MM, +12% from 2Q12. (U.S. +11%, ex-U.S. +20%) (
2Q13 Revenue: Globus Medical
$107MM, +12% (U.S. $98.1MM, +11%; ex-U.S. $8.9MM, +20%) Disruptive Technology $44MM, +27% Innovative Fusion $63MM, +3%   Payer pushback appears to have stabilized Pricing pressure remains in low- to mid-s...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group